River Valley Investors (RVI) is a Western Massachusetts-based group of individual investors working in concert to find high quality private equity investment opportunities in both early stage companies with significant growth potential as well as later stage companies.

Prismic Pharmaceuticals is a development-stage specialty pharmaceutical company that focuses on the research and development of patent protected products with unique safety profiles to address inflammation and oxidative stress associated with Renal and Mental Health Disorders. Inflammation and oxidative stress are thought to be underlying causes of many of the most commonly occurring disorders associated with the aging “baby boomer” population. This includes Chronic Kidney Disease (CKD) which is frequently a consequence of Diabetes, a disorder with an increasing incidence in the United States and most of the developed world. Similarly, there is an increasing incidence of Depression. CKD and Depressive Disorders are key areas of strategic focus for Prismic Pharmaceuticals.

Gets entrepreneurs from launch to their first $10 million in revenue.

FSD Pharma is committed to our pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market. Through our rigorous drug development pipeline, we are closer to achieving our mission of obtaining Total Brain Health for all. FSD Pharma is rapidly advancing our compounds through preclinical and clinical development to help treat individuals affected by Multiple Sclerosis and mental health diseases. Follow along as we develop hope for a positive tomorrow.

The CNS Company (TCNSC) is the ONLY CRO that is exclusively focused on conducting clinical trials in CNS diseases. We team have over 15 years of experience in this challenging area covering diseases as diverse as Alzheimer's disease, Traumatic Brain Injury and schizophrenia, and orphan diseases such as Huntington's disease and frontotemporal dementia. We offer the full service and work globally. With its subjective assessments and often subjective diagnosis, along with lack of biomarkers and high placebo response, CNS is like no other therapeutic area. TCNSC have a wealth of experience in CNS clinical trial design, understand the strengths and weaknesses of a multitude of subjective and objective assessments used in CNS studies, and have excellent, long term relationships with neurologists and psychiatrists enabling outstanding recruitment. TCNSC personnel are also experienced in attending meetings with FDA and EMA, negotiating Special Protocol Assessment with the FDA and obtaining Scientific Advice with the EMA on specific projects within the CNS arena. The staff at TCNSC are the world's first CRO team to deliver 437 patients in less than 12 months for a phase III clinical trial in a CNS orphan indication.

Certified Alzheimer's & Dementia Secured Facility servicing Polk County and surrounding areas.

Primus Pharmaceuticals is a specialty pharmaceutical company the uses time-tested medical ingredients to fill today's unmet medical needs. Utilizing a variety of products such as topical dermatology drugs, a medical device, and medical foods, Primus is meeting the needs of patients safely, without compromising efficacy. Our Topical Dermatological drugs provide elegant proprietary delivery systems superior to generics with greater patient acceptance and persistency. Our Medical Device contains no active ingredient but works with the body’s own physiology to promote wellness through the body’s natural processes. Finally, our Medical Foods are safe and efficacious alternatives to traditional medicine with plant-based prescription products. Primus Pharmaceuticals is a unique, innovative company that empowers providers, and patients centric with prescription brands that maintain the highest level of safety without compromising efficacy. THERAPEUTIC CATEGORIES Dermatology Rheumatology Internal Medicine Vascular Health (Phlebology) Obstetrics/Gynecology Pain Management Orthopedics Podiatry